Medipyrin

Paracetamol, the active ingredient in Medipyrin, is a Analgesic; Antipyretic presented as a tablet for oral use. It relieves fever, headache, musculoskeletal pain, toothache and other cold‑related symptoms in adults and children when appropriate dosing is generally safely under medical guidance. It is formulated to meet EU quality standards and is widely available in retail pharmacies.

GNH USA supplies Medipyrin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with established distribution networks across Europe, Asia and Africa.

Paracetamol acts centrally to reduce fever and alleviate pain, making it suitable for several common conditions.

Fever: lowers body temperature and provides comfort. Headache: eases tension and migraine‑related pain. Musculoskeletal pain: reduces aches associated with strains, sprains and arthritis. Toothache: diminishes dental pain and inflammation. Cold symptoms: helps relieve mild fever and headache accompanying upper‑respiratory infections.

Paracetamol is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Nausea: mild stomach upset after ingestion. - Abdominal discomfort: transient stomach pain. - Headache: occasional worsening of existing headache. - Skin rash: mild itching or erythema. - Dizziness: brief light‑headedness. - Elevated liver enzymes: mild, reversible changes.

Serious or Rare Side Effects: - Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Acute liver failure: especially with overdose or chronic high intake. - Blood disorders: agranulocytosis or thrombocytopenia. - Anaphylaxis: rare severe allergic response.

When using Medipyrin, certain precautions help minimize risk and ensure safe use.

Liver function monitoring: avoid use in patients with severe hepatic impairment. Alcohol consumption: limit alcohol to reduce liver stress. Maximum daily dose: do not exceed the recommended total paracetamol amount from all sources. Use in children: follow pediatric dosing guidelines and avoid use in infants under 2 months. Concomitant paracetamol products: avoid simultaneous use of other paracetamol‑containing medicines. Store at room temperature: keep in the original pack, protect from moisture and heat.

Paracetamol may interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Warfarin: increased risk of bleeding. - Carbamazepine: reduced analgesic effect. - Isoniazid: heightened hepatotoxic potential. - Alcohol: additive liver toxicity.

Moderate Interactions (Monitor Closely): - Oral contraceptives: possible reduction in contraceptive effectiveness. - Phenytoin: altered plasma levels of both drugs. - HIV protease inhibitors: may increase paracetamol plasma concentrations.